Annonce

Log ud Log ind
Log ud Log ind
Formue

Nvidia skuffelse vil rive hele markedet med ned

Morten W. Langer

onsdag 21. februar 2024 kl. 18:13

Guide: Opnå konkurrencefordele ved offensiv brug af AI

Uddrag fra Zerohedge:

The big question is, what can we do about this extreme outlier risk as NVDA has now become a ‘macro’ factor.

Following a monster 2023 (+346%) and a huge rally YTD (+40%) NVDA is now the 3rd highest market cap name in the US.

Given its prominent rise, NVDA has become a large driver and contributor of market returns, so as Goldman trader Guillaume Soria explains in a note this morning, a sell-off in the name would not only hurt portfolios that hold the name, but would also ripple through the market across the momentum factor and consensus trades.

Macro Implications for Momentum:

Over the last 5 years, on the 6 instances where Mega Cap Tech had a 5-day drawdown greater than 10% (median ~12%), the SPX followed suit and was down ~9%. The underperformance of the index was driven by the weight of Mega Cap in the index (currently standing at 27%) and the beta to the market. While momentum has typically been resilient to Mega Cap Tech sell off, this event is different because:

  • NVDA’s 2.6 loading to the momentum factor and the convergence of long momentum and AI Beneficiaries, which were some of the top winners in 2023, could lead to a subsequent move across the space.
  • Momentum Positioning & technical indicators are stretched with gross leverage at 99th  percentile on a 5yr lookback, systematic Momentum exposure at 90th percentile,  and US Momentum RSI breaching 80 last week and remaining in overbought territory.

Momentum remains overbought…

Source: Goldman Sachs

Systematic Exposure to Momentum is very elevated…

90th percentile

Source: Goldman Sachs

Crowding Risk is high…

Correlation between Megacap, Hedge Fund Crowding, Momentum and Size trades is almost 2x the historical average correlation…

Vær et skridt foran

Få unik indsigt i de vigtigste erhvervsbegivenheder og dybdegående analyser, så du som investor, rådgiver og topleder kan handle proaktivt og kapitalisere på ændringer.

399,-

pr. måned

Allerede abonnent? Log ind her

Tilmeld dig vores gratis nyhedsbrev
ØU Dagens Nyheder Middag - Investering

Vær et skridt foran. Få de vigtigste analyser af danske aktier og aktiemarkedet
Udkommer hver dag kl. 12.

Jeg giver samtykke til, at I sender mig mails med de seneste historier fra Økonomisk Ugebrev. Lejlighedsvis må I gerne sende mig gode tilbud og information om events. Samtidig accepterer jeg ØU’s Privatlivspolitik.

Du kan til enhver tid afmelde dig med et enkelt klik.

[postviewcount]

Jobannoncer

No data was found

Mere fra ØU Formue

Log ind

Har du ikke allerede en bruger? Opret dig her.

Påskegave

Få to GRATIS analyser af Novo Nordisk & Zealand Pharma 

*Tilbuddet gælder ikke, hvis man har været abonnent indenfor de seneste 6 måneder

FÅ VORES STORE NYTÅRSUDGAVE AF FORMUE

Her er de 10 bedste aktier i 2022

Tilbuddet udløber om:
dage
timer
min.
sek.

Analyse af og prognoser for Fixed Income (statsrenter og realkreditrenter)

Direkte adgang til opdaterede analyser fra toneangivende finanshuse:

Goldman Sachs

Fidelity

Danske Bank

Morgan Stanley

ABN Amro

Jyske Bank

UBS

SEB

Natixis

Handelsbanken

Merril Lynch 

Direkte adgang til realkreditinstitutternes renteprognoser:

Nykredit

Realkredit Danmark

Nordea

Analyse og prognoser for kort rente, samt for centralbankernes politikker

Links:

RBC

Capital Economics

Yardeni – Central Bank Balance Sheet 

Investing.com: FED Watch Monitor Tool

Nordea

Scotiabank